214 related articles for article (PubMed ID: 19317426)
1. Steroid and protein ligand binding to cytochrome P450 46A1 as assessed by hydrogen-deuterium exchange and mass spectrometry.
Liao WL; Dodder NG; Mast N; Pikuleva IA; Turko IV
Biochemistry; 2009 May; 48(19):4150-8. PubMed ID: 19317426
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain.
Mast N; White MA; Bjorkhem I; Johnson EF; Stout CD; Pikuleva IA
Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9546-51. PubMed ID: 18621681
[TBL] [Abstract][Full Text] [Related]
3.
Mast N; Anderson KW; Johnson KM; Phan TTN; Guengerich FP; Pikuleva IA
J Biol Chem; 2017 Aug; 292(31):12934-12946. PubMed ID: 28642370
[TBL] [Abstract][Full Text] [Related]
4. Combined use of mass spectrometry and heterologous expression for identification of membrane-interacting peptides in cytochrome P450 46A1 and NADPH-cytochrome P450 oxidoreductase.
Mast N; Liao WL; Pikuleva IA; Turko IV
Arch Biochem Biophys; 2009 Mar; 483(1):81-9. PubMed ID: 19161969
[TBL] [Abstract][Full Text] [Related]
5. Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity.
Anderson KW; Mast N; Hudgens JW; Lin JB; Turko IV; Pikuleva IA
J Biol Chem; 2016 May; 291(22):11876-86. PubMed ID: 27056331
[TBL] [Abstract][Full Text] [Related]
6. Substrate-induced modulation of protein-protein interactions within human mitochondrial cytochrome P450-dependent system.
Yablokov EO; Sushko TA; Kaluzhskiy LA; Kavaleuski AA; Mezentsev YV; Ershov PV; Gilep AA; Ivanov АS; Strushkevich NV
J Steroid Biochem Mol Biol; 2021 Apr; 208():105793. PubMed ID: 33271253
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of steroid binding and oxidation by the cytochrome P450 CYP109E1 from Bacillus megaterium.
Jóźwik IK; Kiss FM; Gricman Ł; Abdulmughni A; Brill E; Zapp J; Pleiss J; Bernhardt R; Thunnissen AW
FEBS J; 2016 Nov; 283(22):4128-4148. PubMed ID: 27686671
[TBL] [Abstract][Full Text] [Related]
8. The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo.
Shafaati M; Mast N; Beck O; Nayef R; Heo GY; Björkhem-Bergman L; Lütjohann D; Björkhem I; Pikuleva IA
J Lipid Res; 2010 Feb; 51(2):318-23. PubMed ID: 19474457
[TBL] [Abstract][Full Text] [Related]
9. The cytochrome P450 24A1 interaction with adrenodoxin relies on multiple recognition sites that vary among species.
Estrada DF
J Biol Chem; 2018 Mar; 293(11):4167-4179. PubMed ID: 29371396
[TBL] [Abstract][Full Text] [Related]
10. CYP46A1-dependent and independent effects of efavirenz treatment.
Mast N; El-Darzi N; Petrov AM; Li Y; Pikuleva IA
Brain Commun; 2020; 2(2):fcaa180. PubMed ID: 33305262
[TBL] [Abstract][Full Text] [Related]
11. Binding of cytochrome P450 27C1, a retinoid desaturase, to its accessory protein adrenodoxin.
Glass SM; Webb SN; Guengerich FP
Arch Biochem Biophys; 2021 Dec; 714():109076. PubMed ID: 34732331
[TBL] [Abstract][Full Text] [Related]
12. SPR-Based study of affinity of cytochrome P450s / redox partners interactions modulated by steroidal substrates.
Ershov PV; Yablokov ЕO; Florinskaya AV; Mezentsev YV; Kaluzhskiy LА; Tumilovich AM; Gilep АА; Usanov SA; Ivanov АS
J Steroid Biochem Mol Biol; 2019 Mar; 187():124-129. PubMed ID: 30468857
[TBL] [Abstract][Full Text] [Related]
13. Specificity of the Redox Complex between Cytochrome P450 24A1 and Adrenodoxin Relies on Carbon-25 Hydroxylation of Vitamin-D Substrate.
Kumar A; Estrada DF
Drug Metab Dispos; 2019 Sep; 47(9):974-982. PubMed ID: 31289106
[TBL] [Abstract][Full Text] [Related]
14. A large-scale comparative analysis of affinity, thermodynamics and functional characteristics of interactions of twelve cytochrome P450 isoforms and their redox partners.
Yablokov EO; Sushko TA; Ershov PV; Florinskaya AV; Gnedenko OV; Shkel TV; Grabovec IP; Strushkevich NV; Kaluzhskiy LA; Usanov SA; Gilep AA; Ivanov AS
Biochimie; 2019 Jul; 162():156-166. PubMed ID: 31034920
[TBL] [Abstract][Full Text] [Related]
15. Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain.
Mast N; Norcross R; Andersson U; Shou M; Nakayama K; Bjorkhem I; Pikuleva IA
Biochemistry; 2003 Dec; 42(48):14284-92. PubMed ID: 14640697
[TBL] [Abstract][Full Text] [Related]
16. Functional interactions of adrenodoxin with several human mitochondrial cytochrome P450 enzymes.
Child SA; Reddish MJ; Glass SM; Goldfarb MH; Barckhausen IR; Guengerich FP
Arch Biochem Biophys; 2020 Nov; 694():108596. PubMed ID: 32980349
[TBL] [Abstract][Full Text] [Related]
17. Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1.
Mast N; Zheng W; Stout CD; Pikuleva IA
Mol Pharmacol; 2013 Jul; 84(1):86-94. PubMed ID: 23604141
[TBL] [Abstract][Full Text] [Related]
18. Ligand-induced conformational changes in the acetylcholine-binding protein analyzed by hydrogen-deuterium exchange mass spectrometry.
Shi J; Koeppe JR; Komives EA; Taylor P
J Biol Chem; 2006 Apr; 281(17):12170-7. PubMed ID: 16484218
[TBL] [Abstract][Full Text] [Related]
19. Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes.
Petrov AM; Mast N; Li Y; Denker J; Pikuleva IA
Brain Commun; 2020; 2(1):. PubMed ID: 32661514
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of bovine adrenodoxin by protein kinase CK2 affects the interaction with its redox partner cytochrome P450scc (CYP11A1).
Bureik M; Zöllner A; Schuster N; Montenarh M; Bernhardt R
Biochemistry; 2005 Mar; 44(10):3821-30. PubMed ID: 15751958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
